Plastic Surgery Practice recently reported on Kythera's upcoming filler, which is currently titled "ATX-104."
Kythera’s recent announcement of their light activation process of wrinkle fillers represents the logical next step in non-invasive facial contouring. At the present time, physician injectors inject wrinkle fillers into the skin and with that the technique ends.
Once the filler is injected into the skin there is very little that can be done to modify that treatment. Because of this, patients do the best with expert injectors who have years of experience. Kythera’s process will allow us to modulate, with light sources, the filler even after it is injected into the skin. The will allow for even better contouring then we are currently able to achieve. This process also marries the exciting laser/light developments of the past 2 decades with today’s wrinkle filler treatments.
Kythera is a leader in the area of new innovative non-invasive treatments. We are currently involved in FDA trials of their fat melting substance – deoxycholate. Companies such as Kythera are leading us into the next generation of cosmetic treatments. What remains unknown is when these treatments will receive FDA approval.
Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center, Boca Raton
Skin Laser Surgery Specialists of NY/NJ
Dr. Jason Pozner
Sanctuary Medical Aesthetic Center, Boca Raton
Sanctuary Plastic Surgery, Boca Raton
